PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

New Vernon Capital Holdings II LLC's Holding History (CIK: 0001512538)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 4,137 Value ($000) $361 Avg Close $81.85 Range $62.24 - $96.54

Q3 2025

Shares 7,198 Value ($000) $478 Avg Close $56.84 Range $49.38 - $68.26

Q2 2025

Shares 7,198 Value ($000) $398 Avg Close $47.99 Range $39.60 - $57.70

Q1 2025

Shares 348,095 Value ($000) $7 Avg Close $41.90 Range $33.70 - $60.60

Q4 2024

Shares 3,061 Value ($000) $118 Avg Close $43.60 Range $33.31 - $48.89

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	4,137	$361	$81.85	$62.24 - $96.54
Q3 2025	7,198	$478	$56.84	$49.38 - $68.26
Q2 2025	7,198	$398	$47.99	$39.60 - $57.70
Q1 2025	348,095	$7	$41.90	$33.70 - $60.60
Q4 2024	3,061	$118	$43.60	$33.31 - $48.89